Pre-publication history
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
-
* Corresponding author: Helena Linardou elinardou@otenet.gr
BMC Medicine 2010, 8:3 doi:10.1186/1741-7015-8-3
Pre-publication versions of this article and reviewers' reports
| Resubmission - Version 2 | Manuscript | Author's comment | 18 Nov 2009 |
| Editor's comment | Editor's comment | 23 Nov 2009 | |
| Editorial acceptance | 23 Nov 2009 | ||
| Published | 07 Jan 2010 |